Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ardea Biosciences, Inc.    RDEA

 SummaryNewsCalendarCompanyFinancials 
Company
More about the company
Latest news on ARDEA BIOSCIENCES, INC.
2012 AstraZeneca hungry to refill medicine cabinet
2012DJAstraZeneca Completes Acquisition of Ardea Biosciences
2012 GSK goes hostile with $2.6 billion Human Genome offer
2012 Biotech targets fight back as Big Pharma circles
2012 ARDEA BIOSCIENCES, INC. : Securities Lawyers at Goldfarb LLP Seeking More Money,..
2012 Warner Chilcott to explore sale of company
2012 ARDEA BIOSCIENCES, INC. : Law Office of Brodsky & Smith, LLC Announces Investiga..
2012DJPharma M&A Surge Spurred By Necessity And Opportunity
2012 AstraZeneca CEO quits as drug sales tumble
2012 Watson to buy Actavis for at least $5.6 billion
More news
Sector news : Bio Therapeutic Drugs
01:22p GSK chases next biotech asthma drug with 175 million pounds J&J deal
07/26 GILEAD SCIENCES : cuts 2016 sales forecast, cites hepatitis C drugs
07/25DJGILEAD SCIENCES : Sales of Hepatitis C Drugs Fall 19% -- 2nd Update
07/25DJCELGENE : Drug Misses Secondary Endpoint in One of Its Lymphoma Trials
07/25DJGILEAD SCIENCES : Sales of Hepatitis C Drugs Fall 19% -- 3rd Update
More sector news : Bio Therapeutic Drugs
Advertisement
Income Statement Evolution
More Financials
Sector and Competitors
1st jan.Capitalization (M$)
ARDEA BIOSCIENCES, INC..0
AMGEN, INC.3.29%125 957
GILEAD SCIENCES, INC.-19.90%107 944
CELGENE CORPORATION-11.34%82 247
REGENERON PHARMACEUTIC..-27.26%41 850
VERTEX PHARMACEUTICALS..-24.52%23 493
More Results